• HIF-1–Induced tiRNA-Lys-CTT-003 Protects Renal Tubules from

  2026-08-03

  This study identifies a novel mechanism by which HIF-1α-induced tiRNA-Lys-CTT-003 protects renal tubular epithelial cells from cisplatin-induced ferroptosis in acute kidney injury (AKI). The data reveal that tiRNA-Lys acts through interaction with GRSF1 to upregulate GPX4, thereby limiting ferroptotic cell death and improving renal function.

• Tomivosertib Suppresses Spontaneous Activity in Human DRG Ne

  2026-08-03

  This study provides the first direct evidence that tomivosertib, a selective MNK inhibitor, rapidly and reversibly suppresses spontaneous activity in human dorsal root ganglion neurons from radiculopathy patients. The findings highlight MNK signaling as a central driver of neuropathic pain and suggest MNK inhibition as a promising translational target for pain therapeutics.

• Applied Native Protein Gel Electrophoresis with K4142 Kit

  2026-08-02

  The Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) empowers researchers to resolve and study acidic proteins in their native, biologically active forms. This article delivers optimized workflows, troubleshooting strategies, and actionable insights—bridging mechanistic protein analysis to translational research needs.

• Ferulic Acid Attenuates Chemotherapy-Induced POI via ER Stre

  2026-08-01

  This study demonstrates that ferulic acid alleviates chemotherapy-induced premature ovarian insufficiency (POI) in mice by targeting the Grp78 and Perk-eIF2α-ATF4-CHOP pathway to reduce endoplasmic reticulum (ER) stress and granulosa cell apoptosis. The findings offer mechanistic insight into ER stress modulation as a viable route for ovarian protection and highlight translational opportunities for developing targeted therapies.

• BRD4 Inhibition Broadly Sensitizes Cells to Ferroptosis via

  2026-07-31

  This study reveals that inhibition of BRD4, including with I-BET-762, robustly enhances erastin-induced ferroptosis across a diverse panel of cell lines by promoting ROS accumulation and downregulating FSP1. These findings clarify the mechanistic interplay between BET inhibition and ferroptosis, offering new strategies for translational research in cancer biology and epigenetic regulation.

• U-73122: Phospholipase C Inhibitor for Advanced Pathway Modu

  2026-07-31

  U-73122 is a benchmark phospholipase C inhibitor empowering researchers to dissect PLC-driven signaling in cancer and inflammation. This guide details optimized workflows, real-world troubleshooting, and unique insights drawn from recent breast cancer invasion research—enabling superior experimental control for calcium flux and chemotaxis assays.

• Erlotinib (NSC 718781): Applied Protocols in EGFR Pathway In

  2026-07-30

  Erlotinib (NSC 718781) enables precise dissection of EGFR signaling and resistance mechanisms in cancer models. This article delivers protocol-driven guidance, data-backed troubleshooting, and actionable insights for optimizing EGFR autophosphorylation inhibition assays and translational research.

• Exendin-4 (Exenatide): Accelerating Beta Cell and Diabetes R

  2026-07-30

  Exendin-4 unlocks robust, reproducible workflows for beta cell function and type 2 diabetes research, bridging in vitro and in vivo applications. Recent advances in yeast-based production and validated APExBIO protocols empower labs to probe insulin sensitivity and hepatic steatosis reversal with unprecedented accessibility.

• tRF16-mediated ALKBH5 Downregulation Drives Osteoarthritis P

  2026-07-29

  This study identifies tRF16 as a critical regulator in osteoarthritis, showing that it promotes disease progression by targeting the m6A demethylase ALKBH5 and destabilizing NFKBIA mRNA. These findings deepen our understanding of noncoding RNA involvement in OA and highlight potential biomarkers and therapeutic targets.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody in Advanced Immunoass

  2026-07-29

  The Cy3 Goat Anti-Mouse IgG (H+L) Antibody elevates the sensitivity and reproducibility of immunofluorescence and flow cytometry, enabling precise mouse IgG detection even in complex signaling studies. Its robust signal amplification and low background streamline advanced workflows, making it a go-to tool for researchers tackling cellular signaling and biomarker quantification.

• Brefeldin A: ATPase Inhibitor for ER Stress and Cancer Apopt

  2026-07-28

  Brefeldin A (BFA) is a potent ATPase inhibitor disrupting ER-to-Golgi trafficking and inducing apoptosis in cancer cells. It is widely used to model ER stress and vesicle transport inhibition. APExBIO’s BFA (SKU B1400) offers validated performance in diverse experimental systems.

• Porcupine Inhibition for Sclerosteosis: LGK-974 in Bone Dise

  2026-07-28

  This study demonstrates that PORCN inhibition via LGK-974 can counteract pathological bone overgrowth in sclerosteosis, an ultra-rare high bone mass disorder. The findings highlight a new avenue for pharmacological intervention targeting Wnt/β-catenin signaling, with implications for rare bone diseases lacking effective non-surgical treatments.

• Cisplatin (SKU A8321): Data-Driven Solutions for Cell Assays

  2026-07-27

  This article delivers scenario-driven, evidence-based guidance for maximizing reproducibility and sensitivity in cell viability and apoptosis assays using Cisplatin (SKU A8321). Drawing on recent literature and practical workflow insights, we address experimental design, protocol optimization, and product selection, helping researchers and technicians achieve robust, interpretable results in cancer research.

• Pitavastatin (NK-104): Technical Guide for In Vitro Choleste

  2026-07-27

  Pitavastatin (NK-104) is a high-purity, potent HMG-CoA reductase inhibitor intended for precise in vitro inhibition of cholesterol biosynthesis. It is optimized for use in cellular and biochemical assays relevant to cardiovascular and atherosclerosis research, but is not validated for clinical or in vivo animal experiments.

• TMRE and Mitochondrial Dysfunction: Strategic Advances for T

  2026-07-26

  This thought-leadership article explores how Tetramethylrhodamine ethyl ester perchlorate (TMRE, SKU: C8197) empowers translational researchers to dissect mitochondrial dysfunction and oxidative stress, particularly in the context of toxin-induced liver injury. Integrating mechanistic insights from recent studies on caspase-3-mediated mitochondrial impairment, it provides strategic guidance for leveraging TMRE in live-cell imaging, disease modeling, and therapeutic discovery. The article distinguishes itself by offering actionable protocols, evaluating the competitive landscape, and projecting future directions for mitochondrial research beyond standard product discussions.

15777 records 1/1052 page Next 12345 下5页 Last page